A molecular profile in NSCLC patients: How? When? Why?
Getting the right drug to the right patient based upon molecular profiling
Date
08 Oct 2016Session
A molecular profile in NSCLC patients: How? When? Why?Presenters
Jean-Charles SoriaAuthors
J. SoriaAuthor affiliations
- Dept. Of Medicine, Institut de Cancérologie Gustave Roussy, 94805 - Villejuif/FR
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Organisation: Local, regional and national
Presenter: Fabrice Barlesi
Session: A molecular profile in NSCLC patients: How? When? Why?
Resources:
Slides
Introduction
Presenter: Fiona Blackhall
Session: A molecular profile in NSCLC patients: How? When? Why?
Resources:
Webcast
Conclusions and clinical perspectives
Presenter: Fabrice Barlesi
Session: A molecular profile in NSCLC patients: How? When? Why?
Resources:
Slides
Clinical application of serial molecular biomarker monitoring
Presenter: Stephen Finn
Session: A molecular profile in NSCLC patients: How? When? Why?
Resources:
Slides
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.